-+ 0.00%
-+ 0.00%
-+ 0.00%

Vitanova Life Sciences swings to FY26 net loss of USD 37,304; revenue rises 14% to USD 3.03 million

PUBT·07/29/2026 21:23:56
Listen to the news
Vitanova Life Sciences swings to FY26 net loss of USD 37,304; revenue rises 14% to USD 3.03 million
  • Vitanova Life Sciences posted a net loss of USD 37,304 for fiscal 2026, turning from net income of USD 850,746 a year earlier.
  • Revenue rose 14% to USD 3.03 million, while gross profit fell 42% to USD 910,589.
  • Gross margin narrowed to 30% from 59%, as the mix shifted toward lower-margin healthy food products priced to build demand.
  • General and administrative expense more than quadrupled to USD 733,795, driven by higher legal and professional fees and stock compensation.
  • Net cash from operating activities climbed to USD 814,407 from USD 192,774, lifting cash to USD 1.6 million at year-end.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vitanova Life Sciences Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-005837), on July 29, 2026, and is solely responsible for the information contained therein.